InvestorsHub Logo
Followers 0
Posts 7176
Boards Moderated 0
Alias Born 05/23/2008

Re: None

Saturday, 12/13/2014 12:13:35 AM

Saturday, December 13, 2014 12:13:35 AM

Post# of 38595
WOW! This is going back to Dec. 2012 from SHOM annual report:

RESULTS OF OPERATIONS:

Revenues (for the twelve months ended December 31, 2012)

Revenues for the period was $878,783. We feel strong overall perfomance considering all that has taken place with the onset of competitive bidding. Revenues were managed well thru this process.

All sales transactions were with unrelated parties and with major vendors such as INVACARE, RESPIRONICS, MERITS, RESMED, SMITH DRUG and PINNACLE.

Seems that the respi care via Apena RX is less part of the revenue mix due to the competitive bidding and the instrument tax.

I see how margins are much better in the temp healthcare biz. However, there is a HUGE market in the respiratory medical instrument business and hope he takes that into account.